Acadia Pharmaceuticals, Inc. (ACAD) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.34 -0.37%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) reported Q3 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.9 million.
For earnings history and earnings-related data on Acadia Pharmaceuticals, Inc. (ACAD) click here.
For earnings history and earnings-related data on Acadia Pharmaceuticals, Inc. (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Brinker Int'l (EAT) PT Raised to $260 at DA Davidson, Neutral Rating Maintained
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
